IL33 and cancer: Therefore, IL-33, together with its receptor ST2, forms a functional axis to participate in the modulation of inflammatory disorders.3,4 Since chronic inflammation has long been recognized as one of the main driving factors for cancer development,5,6 there is also great interest in evaluating the role of IL-33/ST2 axis in the progression of many types of cancers.7, , –10